cagrilintide vs semaglutide Cagrilintide–semaglutide (CagriSema) as an add-on to basal insulin in adults with type 2 diabetes (REIMAGINE 3): a randomised, double-blind, placebo-controlled, multicentre, phase 3 study Comparative Weight Loss With CagriSema,

It quiets the cravings Food stays with you longer, helping you feel satisfied between meals and reducing hunger throughout the day

How PlexusDx Supports a More Personalized Approach PlexusDx partners exclusively with licensed 503A compounding pharmacies that provide detailed stability documentation and storage protocols specific to your formulation

But theres a new treatment that has experts buzzing about the benefits: a once-weekly injection called retatrutide with early results comparable to weight loss surgery

That puts the regulatory clock at: Q2 2026: TRIUMPH-1 top-line readout Q3 2026: Detailed presentation at scientific meetings (likely EASD September

Drug-Metabolizing Enzyme- and Transporter- Mediated DDIs of GLP-1 RAs and a Dual GLP-1/GIP RA To date, no clinically relevant drug-metabolizing enzyme- or transporter-mediated DDIs involving GLP-1 RAs or a dual GLP-1/GIP RA have been reported (Table 3)

Some studies have examined intravenous glutathione administration in patients with fatty liver disease, with reports of improved liver enzyme levels (ALT and AST) and markers of oxidative stress